HOME >> BIOLOGY >> NEWS
Amid growing public concerns, bioscience firms begin formalizing ethical decision-making practices

Pharmaceutical, biotechnology and bio-agricultural companies, grappling with an array of complex ethical issues, are gradually formalizing systematic approaches to ethical decision-making, according to a two-year study by leading international ethics and bioscience researchers.

Bioscience companies operations pose many ethical dilemmas. They produce and sell genetically modified foods, conduct gene therapy experiments and embryonic stem cell research to produce new therapies, use animals to test new pharmaceuticals, manipulate life'TMs building blocks, create transgenic animals to produce drugs, commercialize genetic and biological materials, compile and use personal genetic information, and set drug prices for domestic and developing country markets.

Companies of all sizes and in all sectors, faced with growing questions and concerns, are recognizing and acting on public pressure to demonstrate business methods that are not just legal but ethical too, according to research conducted jointly by the Joint Centre for Bioethics (JCB) at the University of Toronto, the Keck Graduate Institute of Applied Life Sciences (Claremont CA), Stanford University (Palo Alto, CA), and l'TMUniversite de Montreal.

More than 100 in-depth interviews with managers and top executives at 13 diverse bioscience firms, large and small, all with reputations for developing new approaches, were conducted to capture and summarize the way the industry innovators today address ethical challenges. The research represents some of the first empirical evidence of how bioscience companies are dealing with ethical issues now, establishing a constructive starting point on which to build.

The research results are newly published in the book Bioindustry Ethics (Elsevier Academic Press), with a summary (and accompanying editorial) published today by PLOS Medicine, the paper entitled "Lessons on Ethical Decision Making fro
'"/>

Contact: Terry Collins
terrycollins@rogers.com
416-538-8712
University of Toronto Joint Center for Bioethics
3-Apr-2006


Page: 1 2 3 4 5

Related biology news :

1. Citrus greening continues to spread in citrus growing areas
2. Threats to wild tigers growing
3. FSU engineering professor growing bone in a lab
4. Use of wind energy in US growing, but planning and guidelines are lacking
5. MIT creates 3-D scaffold for growing stem cells
6. A new approach to growing heart muscle
7. A giant among minnows: Giant danio can keep growing
8. After North Korea test, what can be done to reduce the growing nuclear threat?
9. Genomatix appoints distributor for the growing Chinese market
10. Minimal cocktail for growing human embryonic stem cells established
11. New journal article urges use of animal serum-free media for growing live cells

Post Your Comments:
(Date:8/6/2015)... and TELTOW, Germany , August ... Siggraph Conference, SensoMotoric Instruments (SMI) shows the ... , based on Epson,s Moverio BT-200 see-through ... platform. With this new solution, unprecedented quality and efficiency ... interaction with context-sensitive displays. For the first time, professionals ...
(Date:8/5/2015)... -- According to a new market research ... Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, Defense ... 2020", published by MarketsandMarkets, defines and segments the Physical ... The global PIAM Market is estimated to grow from ... at a CAGR of 14.9 % from 2014 to ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:9/2/2015)... ... September 02, 2015 , ... ... with the use of special anti-vascular endothelial growth factor agents given by injection ... currently does not have a scientific protocol for the many millions diagnosed with ...
(Date:9/2/2015)... Mass. (PRWEB) , ... September 02, 2015 , ... ... includes development of botanical and plant-derived compounds. BCC Research reveals in its ... past 2020 because this market defines the category and generates the most market ...
(Date:9/2/2015)... Israel , September 2, 2015 ... TASE: BOLT) ("BioLight" or the "Company"), a firm ... in ophthalmology and cancer diagnostics, announced today that ... of glaucoma will be delivered at the Ophthalmology ... the European Society of Cataract & Refractive Surgeons ...
(Date:9/2/2015)... ... 02, 2015 , ... Temarry Recycling's new $100,000 waste to ... process and continue to contribute to the sustainability of our natural resources. , ... process has been operating at their Mexico facility, Recicladora Temarry, for the last ...
Breaking Biology Technology:StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2
Cached News: